PER percheron therapeutics limited

Week in perspective, page-9

  1. 3,339 Posts.
    lightbulb Created with Sketch. 166
    Itsa, the interpretation of Mid Year is the middle of the year. The middle of anything is halfway and to be ultra precise it is 182.5 days which was 12.00 midday yesterday. Definitely not any other time in July or August. We have been advised of three sets of news likely to be delivered Mid year, not one has been delivered on time and no retraction of this time frame has been forthcoming. If it was to have any leeway the timing should have been reported as being available by the end of July!
    As a result the lack of news, just like the prior timeframe of news by the end of March, has caused panic and dissatisfaction by many holders.

    The Japanese stem cell retraction has a huge relevance to ANP's SCM going forward. This research if proven by others would have made 1102 SCM unviable to carry further forward.

    Negative article insinuated that all of ISIS's drugs would have the same problem. When something like that is reported, with as far as I know no denial by ISIS, how can you state that it had no relevance to ANP.

    Having said all that I would not be surprised to see the SCM results posted on Friday. Here is hoping because another weekend without news will only exacerbate the situation.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.9¢
Change
-0.001(5.56%)
Mkt cap ! $9.243M
Open High Low Value Volume
0.9¢ 0.9¢ 0.9¢ $501 55.62K

Buyers (Bids)

No. Vol. Price($)
23 6662805 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 1490665 6
View Market Depth
Last trade - 12.32pm 14/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.